Skip to content

Tocofersolan

ALIMENTARY TRACT AND METABOLISM

Also known as: .ALPHA.-TOCOPHEROL, .ALPHA.-TOCOPHEROL, D-, .Alpha.-tocopherol, DL-, alpha-D-Tocopherol, alpha-tocopherol, ALPHA-TOCOPHEROL, D-, alpha-tocopherol, dl-, d-alpha-tocopherol, syntopherol, tocophersolan, vedrop

OfpFDA approvedATC A11HA08

Data last refreshed: (DrugCentral release 2024-11-01)

Key facts

Tocofersolan is an ofp drug catalogued in DrugCentral. DrugCentral lists 2 molecular targets, including GSTP1 and TTPA. Recorded indications include Obstruction of bile duct and Vitamin E deficiency.

  • Approval status: ofp.
  • Molecular targets: GSTP1 and TTPA (2 listed in DrugCentral).
  • Indications: Obstruction of bile duct and Vitamin E deficiency.
  • ATC code: A11HA08 (Other plain vitamin preparations).
  • Molecular formula: C29H50O2; molecular weight 430.72 g/mol.

Indications & contraindications

Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).

Indications (2)

  • Obstruction of bile duct
  • Vitamin E deficiency

Mechanism & targets

Molecular targets (2)

TargetGeneActionActivity
Glutathione S-transferase PGSTP1unknownIC50 6.30
Alpha-tocopherol transfer proteinTTPAunknownKd 5.62

Regulatory approvals (1)

DateAgencyMarketed asApplicantOrphan
—FDA——

ATC classification

ATC codeTherapeutic hierarchy
A11HA08ALIMENTARY TRACT AND METABOLISM › VITAMINS › OTHER PLAIN VITAMIN PREPARATIONS › Other plain vitamin preparations

Reported adverse-event signals

Strongest FDA FAERS disproportionality signals (log-likelihood ratio). A signal is a statistical association in spontaneous reports, not proof that the drug causes the event.

MedDRA termLLR
Macular degeneration485.4
Appendicolith268.7
Therapy cessation241.0
Blood uric acid increased232.4
Blood phosphorus increased222.0
Chronic sinusitis206.6
Electric shock191.2
Appendicitis181.7
Paraesthesia oral168.1
Vaginal flatulence164.6
Procedural pain156.1
Constipation151.5

Chemical structure

Full physicochemical, ADMET and 3D-structure analysis of Tocofersolan is on its molecule page.

Molecular formulaC29H50O2
Molecular weight430.72 g/mol
CAS number—
InChIKeyGVJHHUAWPYXKBD-IEOSBIPESA-N
PubChem CID14985
CC(C)CCC[C@@H](C)CCC[C@@H](C)CCC[C@]1(C)CCC2=C(C)C(O)=C(C)C(C)=C2O1

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

What is Tocofersolan used for?

DrugCentral lists the following indications for Tocofersolan: Obstruction of bile duct and Vitamin E deficiency.

How does Tocofersolan work?

Its molecular targets in DrugCentral include GSTP1 and TTPA.

What is the chemical formula of Tocofersolan?

Tocofersolan has the molecular formula C29H50O2 and a molecular weight of 430.72 g/mol.

Browse: all drugs starting with T · drug guides by category · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Quick facts

StatusOFP
First approval—
AgencyFDA
Targets2
Indications2
FormulaC29H50O2
DrugCentral ID4280
Interactive profile